No Data
No Data
Co-Diagnostics, Inc. to Participate at FIME 2024 in Miami Beach, June 19-21
Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development...
H.C. Wainwright Maintains Co-diagnostics(CODX.US) With Hold Rating, Maintains Target Price $2
H.C. Wainwright analyst Yi Chen maintains $Co-diagnostics(CODX.US)$ with a hold rating, and maintains the target price at $2.According to TipRanks data, the analyst has a success rate of 0.0% and a to
Express News | HC Wainwright & Co. Reiterates Neutral on Co-Diagnostics, Maintains $2 Price Target
Express News | Co-Diagnostics Submits FDA Application For 510(k) Clearance Of Co-Dx PCR Pro Instrument And OTC COVID-19 Test; POC Clearance And Additional Tests To Follow
Express News | Co-Diagnostics, Inc. Submits First FDA 510(K) Application for Co-Dx Pcr Pro Platform
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersCalidi Biotherapeutics (AMEX:CLDI) shares rose 29.7% to $0.25 during Monday's pre-market session. The market value of their outstanding shares is at $16.0 million. Entero Therapeutics (NASDAQ:E
No Data